EASTMAN KODAK COMPANY -- 138 8354, CONC, KODAK POLYMAX T DEVELOPER -- 6750-01-388-0388
===================== Product Identification ===================== Product ID:138 8354, CONC, KODAK POLYMAX T DEVELOPER MSDS Date:01/14/2001 FSC:6750 NIIN:01-388-0388 Status Code:A === Responsible Party === Company Name:EASTMAN KODAK COMPANY Address:343 STATE STREET City:ROCHESTER State:NY ZIP:14650 Country:US Info Phone Num:716-477-3194 MSDS :800- 242-2424 Emergency Phone Num:716-722-5151 Preparer's Name:NOT PROVIDED CAGE:19139 === Contractor Identification === Company Name:EASTMAN KODAK CO GOVERNMENT MARKETS CONTRACTS Address:343 STATE ST Box:City:ROCHESTER State:NY ZIP:14650-1115 Country:US Phone:716-722-5151/(800) 242-2424 CAGE:19139 ============= Composition/Information on Ingredients ============= Ingred Name:WATER CAS:7732-18-5 RTECS #:ZC0110000 Minumum % Wt:50. Maxumum % Wt:55. Other REC Limits:NOT PROVIDED Code:F Code:F Ingred Name:POTASSIUM SULFITE CAS:10117-38-1 RTECS #:WT3530000 Minumum % Wt:15. Maxumum % Wt:20. Other REC Limits:NOT PROVIDED OSHA PEL:NOT PROVIDED ACGIH TLV:NOT PROVIDED Ingred Name:POTASSIUM CARBONATE CAS:584-08-7 RTECS #:TS7750000 Minumum % Wt:10. Maxumum % Wt:15. Other REC Limits:NOT PROVIDED OSHA PEL:NOT PROVIDED ACGIH TLV:NOT PROVIDED Ingred Name:DIETHYLENE GLYCOL CAS:111-46-6 RTECS #:ID5950000 Minumum % Wt:10. Maxumum % Wt:15. Other REC Limits:NOT PROVIDED OSHA PEL:NOT PROVIDED ACGIH TLV:NOT PROVIDED Ingred Name:HYDROQUINONE CAS:123-31-9 RTECS #:MX3500000 = Wt:3. Other REC Limits:NOT PROVIDED OSHA PEL:2 MG/M3 ACGIH TLV:2 MG/M3 EPA Rpt Qty:1 LB DOT Rpt Qty:1 LB Ingred Name:4-(METHYLAMINO)PHENOL SULFATE CAS:55-55-0 RTECS #:SL8650000 < Wt:1. Other REC Limits:NOT PROVIDED OSHA PEL:NOT PROVIDED ACGIH TLV:NOT PROVIDED ===================== Hazards Identification ===================== LD50 LC50 Mixture:NOT PROVIDED Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO Health Hazards Acute and Chronic:INHALATION: LOW HAZARD FOR RECOMMENDED HANDLING. IN CONTACT WITH STRONG ACIDS/IF HEATED, SULFITES MAY LIBERATE SULFUR DIOXIDE GAS. SULFUR DIOXIDE GAS IS IRRITATING TO RESPIRATORY TRACT. ASTHMATICS/HY PERSENSITIVE INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING. EYES: CAUSES SEVERE IRRITATION OR BURNS. SKIN: CAUSES IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION BASED ON HUMAN EXPERIENCE. PROLONGED OR REPEATED CONTACT WITH AQUEOUS SOLUTIONS MAY CAUSE IRRITATION. MAY CAUSE SKIN DEPIGMENTATION. INGESTION: HARMFUL IF SWALLOWED. CAN CAUSE KIDNEY DAMAGE AND CNS EFFECTS FOLLOWING INGESTION. MAY CAUSE I RRITATION OF GASTROINTESTINAL TRACT. Explanation of Carcinogenicity:INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC): HYDROQUINONE - AMERICAN CONFERENCE OF GOVERNMENTAL INDUSTRIAL HYGIENISTS (ACGIH): HYDROQUINONE, A3; CONFIRMED ANIMAL CARCINOGEN WITH UNKNOWN RELEVAN CE TO HUMANS. - NATIONAL TOXICOLOGY PROGRAM (NTP): NONE - OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION (OSHA): NONE Effects of Overexposure:INHALATION: IN CONTACT WITH STRONG ACIDS OR IF HEATED, SULFITES MAY LIBERATE SULFUR DIOXIDE GAS. SULFUR DIOXIDE GAS IS IRRITATING TO RESPIRATORY TRACT. ASTHMATICS OR HYPERSENSITIVE INDIVIDUALS MAY EX PERIENCE DIFFICULT BREATHING. EYES: CAUSES SEVERE IRRITATION OR BURNS. SKIN: CAUSES IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION BASED ON HUMAN EXPERIENCE. PROLONGED OR REPEATED CONTACT WITH AQUEOUS S OLUTIONS MAY CAUSE IRRITATION. MAY CAUSE SKIN DEPIGMENTATION. INGESTION: CAN CAUSE KIDNEY DAMAGE AND CNS EFFECTS FOLLOWING INGESTION. MAY CAUSE IRRITATION OF GASTROINTESTINAL TRACT. Medical Cond Aggravated by Exposure:SOME ASTHMATICS, HYPERSENSITIVE OR SULFITE-SENSITIVE INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING, WHEEZING, CHEST TIGHTNESS, STOMACH UPSET, HIVES, FAINTNESS, WEAKNESS AND DIARRHEA. ======================= First Aid Measures ======================= First Aid:INHALATION: IF SYMPTOMATIC, MOVE TO FRESH AIR. TREAT SYMPTOMATICALLY. GET MEDICAL ATTENTION IF SYMPTOMS PERSIST. EYES: IMMEDIATELY FLUSH WITH WATER FOR 15 MINUTES. GET MEDICAL ATTENTION IMMEDIATELY. S KIN: IMMEDIATELY FLUSH WITH WATER FOR 15 MINUTES WHILE REMOVING CONTAMINATED CLOTHING AND SHOES. IF SKIN IRRITATION OR ALLERGIC SKIN REACTION DEVELOPS, GET MEDICAL ATTENTION. WASH CONTAMINATED CLOTHI NG BEFORE REUSE. DESTROY OR THOROUGHLY CLEAN CONTAMINATED SHOES. INGESTION: ONLY INDUCE VOMITING AT INSTRUCTION OF MEDICAL PERSONNEL. CALL PHYSICIAN OR POISON CONTROL CENTER IMMEDIATELY. NEVER GIVE AN YTHING BY MOUTH TO UNCONSCIOUS PERSON. ===================== Fire Fighting Measures ===================== Flash Point:NONE Extinguishing Media:WATER SPRAY, CARBON DIOXIDE (CO2), DRY CHEMICAL, ALCOHOL FOAM. Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND PROTECTIVE CLOTHING. FIRE OR EXCESSIVE HEAT MAY PRODUCE HAZARDOUS DECOMPOSITION PRODUCTS. Unusual Fire/Explosion Hazard:NONE ================== Accidental Release Measures ================== Spill Release Procedures:FLUSH TO SEWER WITH LARGE AMOUNTS OF WATER. OTHERWISE, ABSORB SPILL WITH VERMICULITE OR OTHER INERT MATERIAL, THEN PLACE IN A CONTAINER FOR CHEMICAL WASTE. CLEAN SURFACE THOROUGHLY TO REMOVE RESIDUAL CONTAMINATION. Neutralizing Agent:NOT PROVIDED ====================== Handling and Storage ====================== Handling and Storage Precautions:KEEP CONTAINER TIGHTLY CLOSED. KEEP AWAY FROM INCOMPATIBLE SUBSTANCES (SEE INCOMPATIBILITY SECTION). Other Precautions:AVOID BREATHING MIST OR VAPOR. DO NOT GET IN EYES AND AVOID CONTACT WITH SKIN AND CLOTHING. USE WITH ADEQUATE VENTILATION. WASH THOROUGHLY AFTER HANDLING. KEEP FROM CONTACT WITH OXIDIZING MATERIALS. ============= Exposure Controls/Personal Protection ============= Respiratory Protection:NONE SHOULD BE NEEDED. A RESPIRATOR SHOULD BE WORN IF HAZARDOUS DECOMPOSITION PRODUCTS ARE LIKELY TO BE OR HAVE BEEN RELEASED. RESPIRATOR TYPE: ACID GAS. SEE STABILITY AND REACTIVITY SECTION. IF RESPI RATORS ARE USED, A PROGRAM SHOULD BE INSTITUTED TO ASSURE COMPLIANCE WITH OSHA STANDARD 29 CFR 1910.134. Ventilation:GOOD GENERAL VENTILATION (TYPICALLY 10 AIR CHANGES PER HOUR) SHOULD BE USED. VENTILATION RATES SHOULD BE MATCHED TO CONDITIONS. Protective Gloves:WEAR IMPERVIOUS GLOVES AND PROTECTIVE CLOTHING APPROPRIATE FOR RISK OF EXPOSURE Eye Protection:WEAR SAFETY GLASSES WITH SIDE SHIELDS (OR GOGGLES). Other Protective Equipment:EYE BATH, WASHING FACILITIES, SAFETY SHOWER Work Hygienic Practices:IT IS A GOOD INDUSTRIAL HYGIENE PRACTICE TO MINIMIZE SKIN CONTACT. Supplemental Safety and Health USE PROCESS ENCLOSURES, LOCAL EXHAUST VENTILATION, OR OTHER ENGINEERING CONTROLS TO MAINTAIN AIRBORNE LEVELS BELOW RECOMMENDED EXPOSURE LIMITS. N/A = NOT APPLICABLE. N/AV = NOT AVAILABLE. N/K = UNKNOW N. N/P = NOT PROVIDED. N/R = NOT RELEVANT. N/D = NOT DETERMINED. N/E = NOT ESTABLISHED. CNS = CENTRAL NERVOUS SYSTEM. ================== Physical/Chemical Properties ================== HCC:B3 NRC/State Lic Num:NOT RELEVANT Boiling Pt:>100.C, 212.F Melt/Freeze Pt:M.P/F.P Text:NOT PROVIDED Decomp Temp:Decomp Text:NOT PROVIDED Vapor Pres:68F: 24 MBAR (18 MM HG) Vapor Density:0.6 Spec Gravity:1.35 pH:11.6 Viscosity:NOT PROVIDED Evaporation Rate & Reference:NOT PROVIDED Solubility in Water:COMPLETE Appearance and Odor:TAN LIQUID. COLORLESS. ODORLESS. Percent Volatiles by Volume:50-55 WT Corrosion Rate:NOT PROVIDED ================= Stability and Reactivity Data ================= Stability Indicator/Materials to Avoid:YES STRONG OXIDIZING AGENTS, STRONG ACIDS Stability Condition to Avoid:NOT PROVIDED Hazardous Decomposition Products:CARBON DIOXIDE, CARBON MONOXIDE, OXIDES OF SULFUR. =================== Toxicological Information =================== Toxicological Information:GENERAL: CONTAINS: DIETHYLENE GLYCOL. CAN CAUSE KIDNEY DAMAGE. CAN CAUSE CNS EFFECTS. IN F-344 RATS, CHRONIC ORAL ADMINISTRATION OF HYDROQUINONE HAS RESULTED IN THE FORMATION OF BENIGN KIDNEY TUMORS T HOUGHT TO BE SECONDARY TO NEPHROPATHY. HYDROQUINONE-INDUCED NEPHROPATHY FOLLOWING ORAL ADMINISTRATION HAS BEEN NOTED IN THE MALE F-344 RAT, BUT NOT IN OTHER SPECIES OR RAT STRAINS TESTED. ALTHOUGH AN INCREASE IN MONONUCLEAR CELL LEUKEMIA IN F-344 FEMALE RATS HAS BEEN REPORTED FOLLOWING CHRONIC ORAL ADMINISTRATION OF HYDROQUINONE, THIS FINDING WAS NOT REPRODUCED IN A SUBSEQUENT STUDY. ===================== Ecological Information ===================== Ecological:THE FOLLOWING PROPERTIES ARE ESTIMATED FROM THE COMPONENTS OF THE PREPARATIONS. POTENTIAL TOXICITY: FISH LC50 MG/L: 1-10. DAPHNID EC50 MG/L: 1-10. ALGAL IC50 MG/L: 10-100. ORGANICS READILY DEGR ADABLE (>70%): YES (14 DAYS). POTENTIAL BIOACCUMULATION: LOG POW <1. COD (APPROXIMATE G/L): 312. BOD5 (APPROXIMATE G/L): 85. POTENTIAL TOXICITY: WASTE TREATMENT MICROORGANISMS EC50 (MG/L): >100. ==================== Disposal Considerations ==================== Waste Disposal Methods:DISCHARGE, TREATMENT, OR DISPOSAL MAY BE SUBJECT TO NATIONAL, STATE, OR LOCAL LAWS. FLUSH TO SEWER WITH LARGE AMOUNTS OF WATER. SINCE EMPTIED CONTAINERS RETAIN PRODUCT RESIDUE, FOLLOW LABEL WARNINGS E VEN AFTER CONTAINER IS EMPTIED. =================== MSDS Transport Information =================== Transport Information:FOR TRANSPORTATION INFORMATION REGARDING THIS PRODUCT CALL THE KODAK WORLDWIDE TRANSPORTATION HAZMAT HOT LINE: (716) 722-2400 BETWEEN 8 A.M. AND 5 P.M. (EASTERN STANDARD TIME), MONDAY THROUGH FRIDAY . ===================== Regulatory Information ===================== SARA Title III Information:CHEMICAL(S) SUBJECT TO THE REPORTING REQUIREMENTS OF SECTION 313 OR TITLE III OF THE SUPERFUND AMENDMENTS AND REAUTHORIZATION ACT (SARA) OF 1986 AND 40 CFR PART 372: HYDROQUINONE Federal Regulatory Information:NOT PROVIDED State Regulatory Information:MATERIAL(S) KNOWN TO THE STATE OF CALIFORNIA TO CAUSE CANCER: NONE MATERIAL(S) KNOWN TO THE STATE OF CALIFORNIA TO CAUSE ADVERSE REPRODUCTIVE EFFECTS: NONE ======================= Other Information ======================= Disclaimer (provided with this information by the compiling agencies): This information is formulated for use by elements of the Department of Defense. The United States of America in no manner whatsoever, expressly or implied, warrants this information to be accurate and disclaims all liability for its use. Any person utilizing this document should seek competent professional advice to verify and assume responsibility for the suitability of this information to their particular situation.